DavidCharlesHendersonMD

PubMed

• Relationship between vasculitis and chronic lymphocytic leukaemia: a correlation without causation.
  David Charles Henderson, Gabrielle Barringer> ;BMJ Case Reports. 2020 Dec 22
• Posttraumatic Stress Disorder Symptoms and Social and Occupational Functioning of People With Schizophrenia.
  Ng LC, Petruzzi LJ, Greene MC, Mueser KT, Borba CPC, Henderson DC> ;J. Nerv. Ment. Dis.. 2016-08-01
• Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.
  Vincenzi B, Greene CM, Ulloa M, Parnarouskis L, Jackson JW, Henderson DC> ;J Psychiatr Pract. 2016-05-01
• Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controll...
  Nasser AF, Henderson DC, Fava M, Fudala PJ, Twumasi-Ankrah P, Kouassi A, Heidbreder C> ;J Clin Psychopharmacol. 2016-04-01
• Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders.
  Chouinard V, Pingali SM, Chouinard G, Henderson DC, Mallya SG, Cypess AM, Cohen BM, Öngür D> ;Psychiatry Res. 2016-03-30
• Delineating responsibility: primary care provider perspective.
  MacLaurin SA, Henderson DC, Freudenreich O> ;Psychiatr Serv. 2015-03-01
• A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and l...
  Vincenzi B, Stock S, Borba CPC, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC> ;Schizophr. Res.. 2014-11-01
• Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.
  Amatniek J, Canuso CM, Deutsch SI, Henderson DC, Mao L, Mikesell C, Rodriguez S, Sheehan J, Alphs L> ;Clin Schizophr Relat Psychoses. 2014-04-01
• No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.
  Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X> ;Schizophr. Res.. 2013-05-01
• An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics.
  Vincenzi B, Borba CP, Gray DA, Copeland PM, Wang X, Fan X, Aragam GG, Henderson DC> ;Ann Clin Psychiatry. 2013-05-01
• No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.
  Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC> ;J Clin Psychopharmacol. 2013-04-01
• Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia.
  Fan X, Borba CPC, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC> ;Acta Psychiatr Scand. 2013-03-01
• Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.
  Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff D, Henderson DC> ;Psychiatry Res. 2012-12-30
• Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia.
  Wang J, Fan X, Liu D, Yi Z, Freudenreich O, Goff D, Henderson DC> ;Schizophr. Res.. 2012-09-01
• Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder.
  Thakurathi N, Henderson DC> ;Evid Based Ment Health. 2012-08-01
• Capacity building in global mental health: professional training.
  Fricchione, G. L., Borba, C. P., Alem, A., Shibre, T., Carney, J. R., Henderson, D. C.> ;Harv Rev Psychiatry. 2012 Feb 18
• Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.
  Borba, C. P., Fan, X., Copeland, P. M., Paiva, A., Freudenreich, O., Henderson, D. C.> ;J Clin Psychopharmacol. 2011 Oct
• Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients.
  Tranulis, C., Goff, D., Henderson, D. C., Freudenreich, O.> ;Psychiatr Serv. 2011 Aug
• Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia.
  Henderson, D. C., Freudenreich, O., Borba, C. P., Wang, X., Copeland, P. M., Macklin, E., Fan, X., Cather, C., Goff, D. C.> ;Schizophr Res. 2011 Aug
• A high-density quantitative nuclease protection microarray platform for high throughput analysis of gene expression.
  Bourzac, K. M., Rounseville, M. P., Zarate, X., Maddula, V. S., Henderson, D. C., Luckey, J. A., Seligmann, B., Galbraith, D. W.> ;J Biotechnol. 2011 Jun 10
• No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia.
  Fan, X., Copeland, P. M., Liu, E. Y., Chiang, E., Freudenreich, O., Goff, D. C., Henderson, D. C.> ;J Clin Psychopharmacol. 2011 Apr
• Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia.
  Wang, J., Liu, E. Y., Freudenreich, O., Goff, D., Henderson, D. C., Fan, X.> ;Schizophr Res. 2010 Dec
• Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic...
  Fan, X., Liu, E.Y., Hoffman, V.P., Potts, A.J., Sharma, B., Henderson, D.C.> ;J Clin Psychiatry. 2011 Jun
• Lithium to allow clozapine prescribing in benign ethnic neutropenia.
  Nykiel, S., Henderson, D., Bhide, G., Freudenreich, O.> ;Clin Schizophr Relat Psychoses. 2010 Jul
• Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts.
  Zárate, X., Henderson, D. C., Phillips, K. C., Lake, A. D., Galbraith, D. W.> ;Proteome Sci. 2010
• Join now to see all